Signaling, stress response and apoptosis in pre-diabetes and diabetes: Restoring immune balance in mice with alloxan-induced type 1 diabetes mellitus

International Immunopharmacology

Volumn 31, Issue , 2016, Pages 24-31

  Novoselova, Elena G ^a   Glushkova, Olga V ^a   Lunin, Sergey M ^a   Khrenov, Maxim O ^a   Novoselova, Tatyana V ^a   Parfenyuk, Svetlana B ^a   Fesenko, Evgeny E ^a  

^a INSTITUTE OF CELL BIOPHYSICS   (Russian Federation)

Author keywords

Antioxidants; Caspase 3; Cytokines; Heat shock proteins; IKK Inhibitor XII; NF B; SAPK JNK; Thymulin; Type 1 diabetes

Indexed keywords

ANTIOXIDANT; GAMMA INTERFERON; GLUCOSE; HEAT SHOCK PROTEIN 72; HEAT SHOCK PROTEIN 90 ALPHA; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; STRESS ACTIVATED PROTEIN KINASE; THYMULIN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; ALLOXAN; CYTOKINE; STRESS ACTIVATED PROTEIN KINASE 1;

ALLOXAN-INDUCED DIABETES MELLITUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOKINE RESPONSE; DIABETES MELLITUS; DIET; ENZYME ACTIVATION; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; IMMUNITY; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; IMMUNOREGULATION; IMPAIRED GLUCOSE TOLERANCE; MALE; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STRESS; THYMUS; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; CHEMICALLY INDUCED; DIABETES MELLITUS, TYPE 1; DRUG EFFECTS; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; PANCREAS ISLET BETA CELL; PHYSIOLOGICAL STRESS; PHYSIOLOGY;

ALLOXAN; ANIMALS; ANTIOXIDANTS; APOPTOSIS; CYTOKINES; DIABETES MELLITUS, TYPE 1; HUMANS; INSULIN-SECRETING CELLS; MALE; MICE; MICE, INBRED BALB C; MITOGEN-ACTIVATED PROTEIN KINASE 8; NF-KAPPA B; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL; THYMIC FACTOR, CIRCULATING; TOLL-LIKE RECEPTOR 4;

EID: 84949575620     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2015.11.007     Document Type: Article

References (27)

1. A. Khadra, P. Santamaria, and L. Edelstein-Keshet The role of low avidity T cells in the protection against type 1 diabetes: a modeling investigation J. Theor. Biol. 256 2009 126 141
2. M. Lee, J.L. Saver, K.-S. Hong, and et al. Effect of pre-diabetes on future risk of stroke: meta-analysis BMJ 344 2012 e3564
3. R.A. DeFronzo, and M. Abdul-Ghani Assessment and treatment of cardiovascular risk in prediabetes: impaired glucose tolerance and impaired fasting glucose Am. J. Cardiol. 108 3 Suppl. 2011 3 24B
4. M. Surbatovic, M. Veljovic, J. Jevdjic, and et al. Immunoinflammatory response in critically ill patients: severe sepsis and/or trauma Mediat. Inflamm. 2013 362793
5. E.G. Novoselova, M.O. Khrenov, O.V. Glushkova, and et al. Anti-inflammatory effects of IKK Inhibitor XII, thymulin, and fat-soluble antioxidants in LPS-treated mice Mediat. Inflamm. 2014 724838
6. S. Papa, F. Zazzeroni, C.G. Pham, C. Bubici, and G. Franzoso Linking JNK signaling to NF-kB: a key to survival J. Cell Sci. 117 2004 5197 5208
7. S. Papa, C. Bubici, F. Zazzeroni, C.G. Pham, and et al. The NF-κB-mediated control of the JNK cascade in the antagonism of programmed cell death in health and diseases Cell Death Differ. 13 2006 712 729
8. W.E. Walker, A.T. Bozzi, and D.B. Goldstein IRF3 contributes to sepsis pathogenesis in the mouse cecal ligation and puncture model J. Leukoc. Biol. 92 2012 1261 1268
9. K. Takeda, T. Kaisho, and S. Akira Toll-like receptors Annu. Rev. Immunol. 21 2003 335 376
10. R. Tisch, and H. McDevitt Insulin-dependent diabetes mellitus Cell 85 1996 291 297
11. J.A. ∅stergaard, M. Bjerre, S.P. Rao, and et al. Mannan-binding lectin in diabetic kidney disease: the impact of mouse genetics in a type 1 diabetes model Exp. Diabetes Res. 2012 678381
12. A. Ceriello New insights on oxidative stress and diabetic complications may lead to a "causal" antioxidant therapy Diabetes Care 26 2003 1589 1596
13. H. Martens, B. Goxe, and V. Geenen The thymic repertoire of neuroendocrine self-peptides: physiological implications in T-cell life and death Immunol. Today 17 1996 312 317
14. V. Geenen Thymus and type 1 diabetes: an update Diabetes Res. Clin. Pract. 98 2012 26 32
15. S.Y. Shieh, M. Ikeda, Y. Taya, and C. Prives DNA damage-induced phosphorylation of p 53 alleviates inhibition by MDM2 Cell 91 1997 325 334
16. T. Fernandes-Alnemri, G. Litwack, and E.S. Alnemri CPP32, a novel human apoptotic protein with homology to Caenorhabditiselegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme J. Biol. Chem. 269 1994 30761 30764
17. D.L. Eizirik, M.L. Colli, and F. Ortis The role of inflammation in insulitis and beta-cell loss in type 1 diabetes Nat. Rev. Endocrinol. 5 2009 219 226
18. A. Amrani, J. Verdaguer, P. Serra, S. Tafuro, and et al. Progression of autoimmune diabetes driven by avidity maturation of a T-cell population Nature 406 2000 739 742
19. M. von Herrath, and G.T. Nepom Animal models of human type 1 diabetes Nat. Immunol. 10 2009 129 132
20. L.R. Filgueiras Jr., J.O. Martins, C.H. Serezani, and et al. Sepsis-induced acute lung injury (ALI) is milder in diabetic rats and correlates with impaired NF-kB activation PLoS One 7 9 2012 e44987
21. A. Rydén, and M. Faresjö Altered immune profile from pre-diabetes to manifestation of type 1 diabetes Diabetes Res. Clin. Pract. 100 1 2013 74 84
22. A. Rydén, J. Ludvigsson, M. Fredrikson, and M. Faresjö General immune dampening is associated with disturbed metabolism at diagnosis of type 1 diabetes Pediatr. Res. 75 2014 45 50
23. E.G. Novoselova, S.M. Lunin, T.V. Novoselova, and et al. Naturally occurring antioxidant nutrients reduce inflammatory response in mice Eur. J. Pharmacol. 615 2009 234 240
24. S.M. Lunin, M.O. Khrenov, T.V. Novoselova, and et al. Thymulin, a thymic peptide, prevents the overproduction of pro-inflammatory cytokines and heat shock protein Hsp70 in inflammation-bearing mice Immunol. Investig. 37 2008 858 870
25. S.M. Lunin, and E.G. Novoselova Thymus hormones as prospective anti-inflammatory agents Expert Opin. Ther. Targets Rev. 14 2010 775 786
26. S.M. Lunin, M.O. Khrenov, T.V. Novoselova, and et al. Modulation of inflammatory response in mice with severe autoimmune disease by thymic peptide thymulin and inhibitor of NF-kappaB signaling Int. Immunopharmacol. 25 2015 260 266
27. N.S. Rial, K. Choi, T. Nguen, and et al. Nuclear factor kappa B (NF-kB): a novel cause for diabetes, coronary artery disease and cancer initiation and promotion Med. Hypotheses 78 2012 29 32